Recently, the nine-valent human papillomavirus (HPV) vaccine, jointly developed by Xiamen University and Xiamen Innovax over 18 ye

weekly promotion xiamen summar 2025-06-06 17:23  4

In 2024, Xiamen Biopharmaceutical Port in Haicang secured approvals for 116 Class III medical devices, with an additional 47 Class

weekly promotion xiamen summar 2025-05-23 20:01  8

The 2025 Fujian Global Innovation and Entrepreneurship Competition officially launched on May 10 to identify, attract and support

weekly promotion xiamen summar 2025-05-16 11:52  9